SPY752.51−0.02%QQQ678.22−0.17%BTC/USD74,711.24−0.73%DIA523.41+0.02%GLD377.85−0.44%TLT81.84−0.15%

Premium Services

Biote Corp

BTMDNASDAQ

Trade with Public

Trade with Public

$1.11

0.054.72%

Last update: Nov 9, 8:15 AM

Overview News Earnings ForecastPrice TargetsFinancials Sentiment Ownership Compare Stock Report

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

Biote (BTMD) Stock Price Target 2026

The average analyst price target for Biote is $5.17, 389.6% above the current price. Of 6 analysts, 5 rate it Buy and 1 Hold. Targets range from $1.50 to $9. The latest change came on Aug 10, 2026, when B. Riley Securities lowered its price target on Biote from $2 to $1.50 and kept a Neutral rating.

The Average Analyst Price Target for Biote is $5.17.

Price Target Range — 7 Quarters

Analyst Consensus — 6 Analysts

5Buy

1Hold

Consensus RatingBuy# Analysts6Avg. Consensus PT$5.17Upside to Avg. PT+389.6%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Biote Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 10, 2026	B. Riley Securities	Jeff Van Sinderen	PT Cut	Neutral	$2→$2
Aug 7, 2026	TD Cowen	Jonna Kim	PT Cut	Buy	$3→$2
Apr 16, 2026	Truist Securities	Gregory Fraser	PT Cut	Buy	$5→$4
Mar 12, 2026	B. Riley Securities	Jeff Van Sinderen	PT Cut	Neutral	$3→$2
Mar 12, 2026	TD Cowen	Jonna Kim	PT Cut	Buy	$3→$3
Aug 7, 2025	B. Riley Securities	Jeff Van Sinderen	Downgrade	Buy→Neutral	$8→$4
Mar 13, 2025	Craig-Hallum	Alex Fuhrman	PT Cut	Buy	$12→$8
Dec 16, 2024	Craig-Hallum	Alex Fuhrman	Initiate	Buy	$12
Mar 13, 2024	Roth MKM	George Kelly	PT Raise	Buy	$8→$9
Feb 20, 2024	B. Riley Securities	Jeff Van Sinderen	Initiate	Buy	$9
Feb 1, 2024	Jefferies	Kaumil Gajrawala	Initiate	Buy	$7
Jan 18, 2024	Truist Securities	Gregory Fraser	PT Cut	Buy	$10→$9
Jan 18, 2024	Roth MKM	George Kelly	PT Cut	Buy	$8→$7

Analyst Ratings News

PRO
B. Riley Securities Maintains Neutral on Biote, Lowers Price Target to $1.5

B. Riley Securities analyst Jeff Van Sinderen maintains Biote (NASDAQ:BTMD) with a Neutral and lowers the price target from $2 to $1.5.

Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on Biote, Lowers Price Target to $2

TD Cowen analyst Jonna Kim maintains Biote (NASDAQ:BTMD) with a Buy and lowers the price target from $2.5 to $2.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Biote, Lowers Price Target to $4

Truist Securities analyst Gregory Fraser maintains Biote (NASDAQ:BTMD) with a Buy and lowers the price target from $5 to $4.

Benzinga Newsdesk

PRO
B. Riley Securities Maintains Neutral on Biote, Lowers Price Target to $2

B. Riley Securities analyst Jeff Van Sinderen maintains Biote (NASDAQ:BTMD) with a Neutral and lowers the price target from $3 to $2.

Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on Biote, Lowers Price Target to $2.5

TD Cowen analyst Jonna Kim maintains Biote (NASDAQ:BTMD) with a Buy and lowers the price target from $3 to $2.5.

Benzinga Newsdesk

PRO
B. Riley Securities Downgrades Biote to Neutral, Lowers Price Target to $4

B. Riley Securities analyst Jeff Van Sinderen downgrades Biote (NASDAQ:BTMD) from Buy to Neutral and lowers the price target from $8 to $4.

Benzinga Newsdesk